| |
 |
ARTICLES
|
|
| On clinical trial participation |
| B Fisher |
|
JCO Nov 1 1991: 1927–1930.
[PDF]
|
 |
|
Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining |
| |
JD Hainsworth, EP Wright, DH Johnson, BW Davis, and FA Greco |
| |
JCO Nov 1 1991: 1931–1938.
[Abstract]
[PDF]
|
 |
|
Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck |
| |
IW Dimery, BJ Brooks, R Winn, T Martin, M Shirinian, and WK Hong |
| |
JCO Nov 1 1991: 1939–1944.
[Abstract]
[PDF]
|
 |
|
Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study |
| |
WK Yung, M Prados, VA Levin, MR Fetell, J Bennett, MS Mahaley, M Salcman, and E Etcubanas |
| |
JCO Nov 1 1991: 1945–1949.
[Abstract]
[PDF]
|
 |
|
Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group |
| |
SD Williams, JA Blessing, KD Hatch, and HD Homesley |
| |
JCO Nov 1 1991: 1950–1955.
[Abstract]
[PDF]
|
 |
|
Maternal and fetal outcome after invasive cervical cancer in pregnancy |
| |
D Zemlickis, M Lishner, P Degendorfer, T Panzarella, SB Sutcliffe, and G Koren |
| |
JCO Nov 1 1991: 1956–1961.
[Abstract]
[PDF]
|
 |
|
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study |
| |
JT Thigpen, JA Blessing, J Beecham, H Homesley, and E Yordan |
| |
JCO Nov 1 1991: 1962–1966.
[Abstract]
[PDF]
|
 |
|
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer |
| |
MA Poon, MJ O'Connell, HS Wieand, JE Krook, JB Gerstner, LK Tschetter, R Levitt, CG Kardinal, and JA Mailliard |
| |
JCO Nov 1 1991: 1967–1972.
[Abstract]
[PDF]
|
 |
|
CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign? |
| |
TB Haddy, MA Adde, and IT Magrath |
| |
JCO Nov 1 1991: 1973–1982.
[Abstract]
[PDF]
|
 |
|
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial |
| |
L Yelle, D Bergsagel, V Basco, T Brown, R Bush, J Gillies, L Israels, A Miller, D Rideout, and D Whitelaw |
| |
JCO Nov 1 1991: 1983–1993.
[Abstract]
[PDF]
|
 |
|
Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients |
| |
P Joly, F Charlotte, M Leibowitch, C Haioun, J Wechsler, F Dreyfus, JP Escande, J Revuz, F Reyes, and B Varet |
| |
JCO Nov 1 1991: 1994–2001.
[Abstract]
[PDF]
|
 |
|
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B |
| |
RR Ellison, R Mick, J Cuttner, CA Schiffer, RT Silver, ES Henderson, T Woliver, I Royston, FR Davey, and AS Glicksman |
| |
JCO Nov 1 1991: 2002–2015.
[Abstract]
[PDF]
|
 |
|
Mesna versus hyperhydration for the prevention of cyclophosphamide- induced hemorrhagic cystitis in bone marrow transplantation |
| |
JD Shepherd, LE Pringle, MJ Barnett, HG Klingemann, DE Reece, and GL Phillips |
| |
JCO Nov 1 1991: 2016–2020.
[Abstract]
[PDF]
|
 |
|
Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients |
| |
LC Platanias, CB Miller, R Mick, RD Hart, H Ozer, JM McEvilly, RJ Jones, and MJ Ratain |
| |
JCO Nov 1 1991: 2021–2026.
[Abstract]
[PDF]
|
 |
|
Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72- hour continuous infusion with and without dipyridamole |
| |
DL Trump, MJ Egorin, A Forrest, JK Willson, S Remick, and KD Tutsch |
| |
JCO Nov 1 1991: 2027–2035.
[Abstract]
[PDF]
|
 |
|
Phase I study of toremifene in patients with advanced cancer [published erratum appears in J Clin Oncol 1992 Apr;10(4):674] |
| |
JT Hamm, DC Tormey, PC Kohler, D Haller, M Green, and I Shemano |
| |
JCO Nov 1 1991: 2036–2041.
[Abstract]
[PDF]
|
 |
|
The calculation of actual or received dose intensity: a comparison of published methods |
| |
DL Longo, PL Duffey, VT DeVita, Jr, MN Wesley, SM Hubbard, and RC Young |
| |
JCO Nov 1 1991: 2042–2051.
[Abstract]
[PDF]
|
 |
|
Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer |
| |
HC Stevenson, I Green, JM Hamilton, BA Calabro, and DR Parkinson |
| |
JCO Nov 1 1991: 2052–2066.
[Abstract]
[PDF]
|
 |
|
Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study |
| |
AB Benson, 3d, JP Pregler, JA Bean, AW Rademaker, B Eshler, and K Anderson |
| |
JCO Nov 1 1991: 2067–2075.
[Abstract]
[PDF]
|
 |
| Fluorouracil/leucovorin study update |
| C Erlichman |
|
JCO Nov 1 1991: 2076a.
[PDF]
|
 |
| Role of radiotherapy in neuroblastoma |
| GJ D'Angio, KK Matthay, and AE Evans |
|
JCO Nov 1 1991: 2076b–2077.
[PDF]
|
 |
| Chemotherapy in advanced gastric carcinoma |
| A Adenis and J Bonneterre |
|
JCO Nov 1 1991: 2077–2078.
[PDF]
|
 |
| Hepatic resection in colorectal carcinoma and survival |
| DE Bergsagel |
|
JCO Nov 1 1991: 2078–2079.
[PDF]
|
 |
| Clinical use of dronabinol |
| TF Plasse |
|
JCO Nov 1 1991: 2079–2080.
[PDF]
|
 |